Karuna Therapeutics, Inc.
DelistedCIK 1771917fmd_1ASK4F6T82805FZ37WM1VX28V5Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Dec 31, 2023, 24 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Total revenues | – | – | 0 | 37 | 11 | 1 |
| Research and development | 12 | 25 | 43 | 128 | 224 | 364 |
| Total operating expenses | 15 | 45 | 72 | 181 | 300 | 495 |
| Operating income | (15) | (45) | (72) | (144) | (290) | (495) |
| Other non-operating income (expense) | (3) | 1 | 3 | 0 | 15 | 62 |
| Income before taxes | (18) | (44) | (69) | (144) | (275) | (433) |
| Income tax expense | 0 | 0 | 0 | 0 | 1 | 1 |
| Net income from continuing operations | (18) | (44) | (69) | (144) | (276) | (434) |
| Net income | (18) | (44) | (69) | (144) | (276) | (434) |